GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Favipiravir Tablets 200mg
B. Favipiravir Tablets 400mg
C. Favipiravir Tablets 800mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Favipiravir Tablets 200mg
Each film-coated tablet contains:
Favipiravir………………...…….200mg
Excipients………………………. q.s.
Colours: Titanium Dioxide USP


B. Favipiravir Tablets 400mg
Each film-coated tablet contains:
Favipiravir……………….…….400mg
Excipients………………………. q.s.
Colours: Red oxide of Iron

C. Favipiravir Tablets 800mg
Each film-coated tablet contains:
Favipiravir……………….…….800mg
Excipients………………………. q.s.
Colours: Yellow oxide of Iron

THERAPEUTIC INDICATIONS:

Favipiravir is uses in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2.
Favipiravir tablets used for the treatment of mild to moderate COVID-19 disease in adults under restricted emergency use.

CAUTION & WARNING:

CAUTION: Swallow complete tablet, do not crush or chew.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
WARNING: Do not administer the drug to women known or suspected to be pregnant.
WARNING: Male patient should use most effective contraceptive methods in sexual intercourse during and for 7 days after the end of treatment.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].
Dosage: As directed by the Physician.
Attach dispensing label as per end country.
NOTE: 14-day oral administration of favipiravir at a dose of 30 mg/kg/day.

Favipiravir Tablets 200mg Technical Specification:

Product Name:Favipiravir Tablets 200mg
Brand Name:Fabitaj
Strength:200mg, 400mg, 800mg
Dosage Form:Film-coated Tablet
Packing:10s, 17s, 34s
Route of Administration:For Oral Use only.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Antiviral
Indication: Favipiravir is uses in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2
Storage:Store at a temperature not exceeding 25°C. Protect from moisture

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Favipiravir Tablets 200mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Favipiravir Tablets 200mg
    Each film-coated tablet contains:
    Favipiravir……………………….200mg
    Excipients………………………. q.s.
    Colours: Titanium Dioxide USP

THERAPEUTIC INDICATIONS:

Favipiravir is uses in the treatment of influenza, Ebola and other pathogenic viral infections. It is also being studied to treat a number of other viral infections, including SARS-CoV-2.

Favipiravir tablets used for the treatment of mild to moderate COVID-19 disease in adults under restricted emergency use.

CAUTION & WARNING:

CAUTION: Swallow complete tablet, do not crush or chew.

Read enclosed leaflet before use.

Keep medicine out of reach of children.

Warning: Do not administer the drug to women known or suspected to be pregnant

Warning: Male patient should use most effective contraceptive methods in sexual intercourse during and for 7 days after the end of treatment.

Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage:  Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Dosage:  As directed by the Physician.

Attach dispensing label as per end country.

NOTE: 14-day oral administration of favipiravir at a dose of 30 mg/kg/day.

Why Taj Pharmaceuticals?

Choose Taj Pharma for your Favipiravir Tablets and experience pharmaceutical expertise at its finest. With a legacy of trust in healthcare, Taj Pharma delivers high-quality medications that make a difference in the fight against viral infections. Our Favipiravir Tablets, known for their efficacy and safety, are manufactured in state-of-the-art facilities, adhering to rigorous quality standards. At Taj Pharma, we prioritize patient well-being, offering accessible and dependable solutions for a wide range of viral illnesses. Trust in Taj Pharma for excellence in pharmaceuticals and a commitment to your health. With a commitment to pharmaceutical excellence, rigorous quality control, and a dedication to patient well-being, Taj Pharma offers reliable and effective solutions for various viral infections. Explore the benefits of choosing Taj Pharma for your Favipiravir needs.

What is Favipiravir Tablets and its use?

Favipiravir Tablets are a medication that contains the active ingredient favipiravir. Favipiravir is an antiviral agent that has been approved for the treatment of certain viral infections. Its primary use is in the management of influenza and, more recently, in the treatment of COVID-19 in some regions, as it has shown potential in clinical trials.

Uses of Favipiravir Tablets:

  • Influenza Treatment: Favipiravir is approved for the treatment of influenza in some countries. It works by inhibiting the replication of the influenza virus, helping to reduce the severity and duration of symptoms.
  • COVID-19 Treatment: In response to the COVID-19 pandemic, some countries have authorized the use of Favipiravir Tablets for the treatment of COVID-19 patients. Clinical studies have been conducted to evaluate its effectiveness in reducing viral load and shortening the duration of symptoms in COVID-19 cases.

It’s important to note that the use of Favipiravir Tablets for COVID-19 treatment may vary by region and is typically prescribed under the guidance of healthcare professionals. The availability and recommended usage of Favipiravir can change over time as new data and guidelines become available. As with any medication, it’s crucial to follow your healthcare provider’s recommendations regarding the use, dosage, and duration of Favipiravir treatment. Self-medication or off-label use should be avoided without proper medical advice, as it may lead to ineffective treatment or potential side effects.

How Does Favipiravir Tablets work?

Favipiravir Tablets work by inhibiting the replication of certain RNA viruses, including influenza viruses and, potentially, the SARS-CoV-2 virus responsible for COVID-19. Favipiravir is classified as a nucleoside analog, which means it mimics the structure of naturally occurring nucleosides that are essential for viral RNA replication.

Here’s how Favipiravir Tablets work:

  • Conversion to Active Form: When Favipiravir is administered orally, it is absorbed into the bloodstream. In the body, it undergoes enzymatic conversion to its active form, favipiravir-RTP (ribonucleoside triphosphate).
  • Incorporation into Viral RNA: The active form, favipiravir-RTP, resembles one of the building blocks (nucleosides) needed for viral RNA synthesis. During viral replication, the virus’s RNA polymerase enzyme mistakenly incorporates favipiravir-RTP into the growing RNA strand instead of the natural nucleosides.
  • Error Catastrophe: The incorporation of favipiravir-RTP into the viral RNA causes errors and mutations in the viral genome. These mutations disrupt the genetic code and lead to nonfunctional or defective viral RNA.
  • Inhibition of Viral Replication: The accumulation of mutations in the viral RNA leads to the inhibition of viral replication. The virus becomes less able to produce functional copies of itself, ultimately reducing its ability to spread and cause infection.

Favipiravir’s mechanism of action is specific to RNA viruses, and its effectiveness may vary depending on the virus’s genetic characteristics. Additionally, while Favipiravir has been authorized for use in some countries for the treatment of COVID-19, its efficacy and safety should be assessed in the context of clinical trials and under the guidance of healthcare professionals. The availability and recommended usage of Favipiravir can change as new data and guidelines become available.

Benefits of Favipiravir Tablets:

  • Antiviral Activity: Favipiravir has demonstrated antiviral activity against a range of RNA viruses, including influenza viruses and, potentially, the SARS-CoV-2 virus responsible for COVID-19. It inhibits viral replication, potentially reducing the severity and duration of viral infections.
  • Potential COVID-19 Treatment: In some regions, Favipiravir Tablets have been authorized for the treatment of COVID-19. Clinical trials have shown that it may help reduce viral load and alleviate COVID-19 symptoms. Its use can be particularly beneficial in cases with mild to moderate symptoms.
  • Influenza Treatment: Favipiravir is approved for the treatment of influenza in some countries. It can reduce the severity of influenza symptoms and shorten the duration of the illness when administered early in the course of the infection.

Side Effects of Favipiravir Tablets:

  • Gastrointestinal Disturbances: Common side effects of Favipiravir may include nausea, diarrhea, and stomach discomfort. These symptoms are generally mild and temporary.
  • Elevated Uric Acid Levels: Favipiravir can lead to an increase in uric acid levels in the blood, which may be a concern for individuals with a history of gout. Monitoring of uric acid levels may be necessary.
  • Potential for Birth Defects: There are concerns about the potential teratogenic (birth defect-causing) effects of Favipiravir. Pregnant individuals and those planning to become pregnant should consult their healthcare providers before using this medication.
  • Drug Interactions: Favipiravir may interact with other medications, so it’s essential to inform your healthcare provider about all the drugs and supplements you are taking.
  • Allergic Reactions: Although rare, allergic reactions to medications can occur. Seek medical attention if you experience symptoms like rash, itching, swelling, or difficulty breathing after taking Favipiravir.
  • Other Potential Side Effects: Some less common side effects reported with Favipiravir use include elevated liver enzymes, changes in white blood cell counts, and central nervous system effects such as confusion.

It’s crucial to use Favipiravir Tablets under the guidance of a healthcare professional, especially when prescribed for COVID-19 treatment. The dosage and duration of treatment should be determined based on individual health needs and the specific viral infection being treated. As with any medication, the benefits and risks should be carefully considered, and any concerns or side effects should be promptly discussed with a healthcare provider.

Frequently asked questions (FAQs) about Favipiravir Tablets:

  1. What are Favipiravir Tablets, and what are they used for?

Favipiravir Tablets contain the active ingredient favipiravir and are used as an antiviral medication. They have been authorized for the treatment of certain viral infections, including influenza and, in some regions, for COVID19.

  1. How does Favipiravir work against viral infections?

Favipiravir works by inhibiting the replication of RNA viruses, including influenza viruses and potentially the SARSCoV2 virus. It does this by causing errors and mutations in the viral genetic material, which disrupts the ability of the virus to reproduce.

  1. Is Favipiravir an effective treatment for COVID19?

Clinical trials have shown that Favipiravir may be effective in reducing viral load and alleviating symptoms of COVID19, especially in cases with mild to moderate symptoms. However, its efficacy may vary, and its use should be based on specific guidelines and under medical supervision.

  1. Can I take Favipiravir Tablets as a preventive measure against COVID19?

Favipiravir is generally prescribed for the treatment of confirmed cases of viral infections and is not typically used as a preventive measure. The use of any medication, including Favipiravir, for prevention should be discussed with a healthcare provider.

  1. Are there any specific contraindications or precautions for using Favipiravir Tablets?

Individuals with certain medical conditions, such as severe kidney impairment or a history of gout, may need special considerations when using Favipiravir. Pregnant individuals and those planning to become pregnant should consult their healthcare providers before use.

  1. Can Favipiravir Tablets be taken with other medications?

Favipiravir may interact with other medications, so it’s important to inform your healthcare provider about all the drugs and supplements you are taking to avoid potential interactions.

  1. What are the common side effects of Favipiravir Tablets?

Common side effects of Favipiravir may include gastrointestinal disturbances like nausea and diarrhea, as well as an increase in uric acid levels. However, not everyone will experience these side effects.

  1. How should I take Favipiravir Tablets?

Follow your healthcare provider’s instructions regarding dosage and timing. Favipiravir is typically administered orally with food to enhance absorption.

  1. Can I take Favipiravir if I am pregnant or breastfeeding?

Pregnant individuals and those breastfeeding should consult their healthcare providers before using Favipiravir, as there may be potential risks that need to be weighed against the benefits.

  1. Is Favipiravir effective against all types of viral infections?

Favipiravir is specifically effective against RNA viruses, including certain influenza viruses and potentially the SARSCoV2 virus. Its efficacy may vary depending on the specific virus and its genetic characteristics.

As Favipiravir Tablets Exporters; We can cater to export business queries from the following geographies. We are exporting our Favipiravir Tablets product in the Following Countries-

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine

GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, and Iraq.

African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia

Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam

Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius

Favipiravir Tablets Regulatory Documents:

  • Certificate of Analysis (COA)
  • Method of Analysis (MOA)
  • Stability Data (Accelerated stability / Long-term stability / Zone 4b)
  • CTD Dossier / ACTD Dossiers / eCTD Dossiers
  • Certificate of Pharmaceuticals Product (COPP)
  • Free Sale Certificate (FSC)
Contact the most reliable manufacturer of Favipiravir Tablets, Taj Pharmaceuticals Limited, to get bulk quantities at a reasonable price.

To Place Orders:

Direct line: +91 8448 444 095 / WhatsApp +91 74 0000 9975 / 74 0000 9976
E-Mail: info@tajpharma.com 
Toll free: 1-800-222-434 / Toll free: 1-800-222-825
General EPA BX: +91 22 2637 4592 / +91 22 2637 4593
Fax No: +91 22 2634 1274